Drug · DIN 02537745
IMCIVREE
1 ML MULTIDOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 12, 2023; first marketed July 12, 2023.
- Drug Identification Number (DIN)
- 02537745
- Company (DIN owner)
- Rhythm Pharmaceuticals, IncBoston, Massachusetts, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Setmelanotide A08AA12
- Class
- Human
- Record last updated
- September 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SETMELANOTIDE (SETMELANOTIDE ACETATE) | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 5, 2023: NOC 30643New Drug Submission (NDS)